DRD3 and psychiatric disorder: By more discussions on the therapeutic effects of blonanserin, which is now known to clearly possess in vivo D3 receptor antagonism, we may be able to consider the relevance of anti-dopamine D3 receptor acivities as well as the therapeutic effects on cognitive impairments and negative symptoms of mental disorders.